on the U.S. economy at $219 billion. Even so, treatment breakthroughs have lagged and the drug often prescribed for the condition, lithium, was first used nearly 75 years ago. With their philanthropic gift, the donors hope to expand the world’s understanding of the disorder and develop new and better ways to treat it.
The BD² effort is being guided by the Milken Institute’s Center for Strategic Philanthropy, an arm of the think tank founded by billionaire former junk-bond king. Cara Altimus of the Center for Strategic Philanthropy will serve as managing director of BD². The effort started about two years ago when the Brin family said they wanted to work on the disorder with the Milken Institute’s guidance. Altimus met the Dauten and Baszucki families and brought them in.
The Dautens and the Baszuckis have already been active donors to bipolar research. The Dautens funded the Dauten Family Center for Bipolar Treatment Innovation at Massachusetts General Hospital in 2017. The family, fans offor why the world needs their research center. Number nine: The last major drug discovery specific to treating bipolar disorder came in 1948 when an Australian researcher accidentally discovered that lithium is an effective mood stabilizer.
KerryDolan Tomorrow they’ll cancel it